First-Line Treatment for HIV-2 (Q65356064)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-Line Treatment for HIV-2 |
clinical trial |
Statements
FIT-2 (English)
0 references
A Randomized, Non-comparative, Phase IIb, Unblinded Trial, Evaluating the Efficacy and Safety of Tenofovir-emtricitabine or Lamivudine Plus Zidovudine, Lopinavir/Ritonavir, or Raltegravir, Among ARV-naïve HIV-2 Infected Adult Patients, in West Africa (English)
0 references
26 January 2016
0 references
July 2019
0 references
210
0 references
18 year
0 references